Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO) announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022, at 2:00 PM ET. The company specializes in bioengineering fully transplantable organs, with a focus on addressing organ shortages through its proprietary perfusion technology platform. Miromatrix aims to help save lives by developing human livers and kidneys. Interested parties can listen to the live event by contacting their BTIG representative.

Positive

• Participation in a significant industry conference provides visibility and networking opportunities.
• Pioneering technology in bioengineering organs addresses critical organ shortages.

Negative

• None.

EDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Miromatrix Medical's management is scheduled to present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Thursday, February 17, 2022 at 2:00 PM ET.

BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

When is Miromatrix Medical's presentation at the BTIG Conference?

Miromatrix Medical will present at the BTIG Conference on February 17, 2022, at 2:00 PM ET.

What is the focus of Miromatrix Medical's technology?

Miromatrix Medical focuses on bioengineering fully transplantable organs, specifically human livers and kidneys.

How can I listen to Miromatrix Medical's presentation at the BTIG Conference?

To listen to Miromatrix Medical's presentation, please contact your BTIG representative for access.

What is the stock symbol for Miromatrix Medical?

The stock symbol for Miromatrix Medical is MIRO.